Showing results (241-250 of 285) with videos related to
Sort By:
Pageof 29
Antiviral Research|January 28, 2014
Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infectionEiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, et al.Journal of Gastroenterology|March 5, 2015
A thymine-adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virusSatoshi Hiramine, Masaya Sugiyama, Norihiro Furusyo, et al.Cancers|September 19, 2020
Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer PatientsPaul König, Markus Eckstein, Rudolf Jung, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 9, 2019
Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort studyEiichi Ogawa, Norihiro Furusyo, Makoto Nakamuta, et al.Journal of Dermatological Science|October 26, 2010
Are lifetime prevalence of impetigo, molluscum and herpes infection really increased in children having atopic dermatitis?Sayaka Hayashida, Norihiro Furusho, Hiroshi Uchi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 22, 2019
Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysisEiichi Ogawa, Hideyuki Nomura, Makoto Nakamuta, et al.Antiviral Research|November 7, 2016
Effectiveness and safety of sofosbuvir plus ribavirin for HCV genotype 2 patients 65 and over with or without cirrhosisEiichi Ogawa, Norihiro Furusyo, Hideyuki Nomura, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 5, 2016
Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosisEiichi Ogawa, Norihiro Furusyo, Naoki Yamashita, et al.BMJ Open|December 22, 2021
Kyushu and Okinawa Population Study (KOPS): a large prospective cohort study in JapanHiroaki Ikezaki, Norihiro Furusyo, Ryoko Nakashima, et al.Journal of Hepatology|August 15, 2012
Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trialNorihiro Furusyo, Eiichi Ogawa, Masayuki Sudoh, et al.Pageof 29